Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
05-09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
05-01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
+9.35% | 4.72B | |
+6.48% | 1.63B | |
+32.11% | 1.25B | |
+82.85% | 881M | |
+22.71% | 851M | |
+27.12% | 585M | |
-28.34% | 553M | |
-.--% | 155M | |
+34.21% | 116M |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.
- Wedbush Starts Cullinan Oncology With Outperform Rating, $30 Price Target